title: Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG.
authors.forename: Ignatius
authors.initials: I
authors.lastname: Chua
authors.forename: Macarena
authors.initials: M
authors.lastname: Lagos
authors.forename: Bambos M
authors.initials: BM
authors.lastname: Charalambous
authors.forename: Sarita
authors.initials: S
authors.lastname: Workman
authors.forename: Ronnie
authors.initials: R
authors.lastname: Chee
authors.forename: Bodo
authors.initials: B
authors.lastname: Grimbacher
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood; D000918:Antibody Specificity; D001424:Bacterial Infections / Q000209:etiology / Q000276:immunology; D003017:Clostridium tetani / Q000276:immunology; D019741:Haemophilus influenzae type b / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000276:immunology* / Q000628:therapy*; D013296:Streptococcus pneumoniae / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous